Plasmajet kINPen® MED
Other
Information
The world’s first plasmajet for the medical application of tissue-compatible cold plasma.
The kINPen® MED product is the first plasmajet CE-marked device for the treatment of chronic wounds and pathogen-induced skin disorders.
The revolutionary technology of the plasmajet kINPen® MED ensures a consistent plasma quality and a controlled treatment process. Physical cold plasma is applied to the wound at a temperature of < 40° Celsius with pinpoint precision and without direct contact, even in the case of complex wounds and wound environments with recesses and cavities. The effect may extend even to chronic wounds that are beyond treatment, which makes it potentially suitable for the prevention of possible amputations. The treatment range of the therapy encompasses inactivation of multi-resistant pathogens such as MRSA and stimulation of tissue regeneration.
